Dr. Reddy's Laboratories Ltd. ADS (RDY) Financials Nov 17,
Dr. Reddy's Laboratories Ltd. ADS (RDY) Financials Nov 17, 2014, 4:01 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Dr. Reddy's Laboratories Ltd. ADS
Fiscal year is April-March. All values INR millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 70.31B 74.69B 96.74B 116.27B 132.17B
Cost of Goods Sold (COGS) incl. D&A 43.48B 36.41B 45.92B 58.25B 59.7B
COGS excluding D&A 39.35B 32.26B 40.7B 52.7B 52.6B
Depreciation & Amortization Expense 4.13B 4.15B 5.21B 5.55B 7.11B
Depreciation 2.65B 2.96B 3.63B 3.86B 4.81B
Amortization of Intangibles 1.48B 1.19B 1.59B 1.69B 2.3B
Gross Income 26.83B 38.29B 50.82B 58.01B 72.47B
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 14.76B 26.77B 32.29B 38.69B 48.35B
Research & Development 3.73B 4.72B 5.53B 7.31B 11.97B
Other SG&A 11.03B 22.05B 26.76B 31.39B 36.38B
Other Operating Expense 1.81B 0 0 (168M) 0
Unusual Expense 4.58B 80M 1.05B (424M) (912M)
EBIT after Unusual Expense (4.58B) (80M) (1.05B) 424M 912M
Non Operating Income/Expense 589M 1.19B 1.63B 1.78B 1.59B
Non-Operating Interest Income 249M 105M 377M 900M 1.09B
Equity in Affiliates (Pretax) 0 - - - -
Interest Expense 312M 289M 1.07B 1.02B 1.27B
Gross Interest Expense 312M 289M 1.07B 1.02B 1.27B
Interest Capitalized 0 0 0 0 0
Pretax Income 6.21B 12.44B 18.41B 21.57B 26.43B
Income Tax 2.69B 1.4B 4.2B 4.9B 5.09B
Income Tax - Current Domestic 2.57B 2.25B 3.62B 4.31B 5.09B
Income Tax - Current Foreign 687M 673M 733M 2.14B 1.47B
Income Tax - Deferred Domestic (154M) (698M) 424M 257M 294M
Income Tax - Deferred Foreign (406M) (825M) (574M) (1.81B) (1.76B)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 3M 54M 104M 174M
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income 3.52B 11.04B 14.26B 16.78B 21.51B
Minority Interest Expense 0 0 0 (1M) (3M)
Net Income 3.52B 11.04B 14.26B 16.78B 21.52B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 - - - -
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 3.52B 11.04B 14.26B 16.78B 21.52B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 3.52B 11.04B 14.26B 16.78B 21.52B
EPS (Basic) 20.83 65.28 84.16 98.82 126.52
Basic Shares Outstanding 168.71M 169.13M 169.47M 169.78M 170.04M
EPS (Diluted) 20.69 64.95 83.81 98.44 126.04
Diluted Shares Outstanding 169.86M 169.97M 170.18M 170.43M 170.7M
EBITDA 14.4B 15.66B 23.74B 25.04B 31.23B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Nailing the U.S. Market with Cold Precision Haier Biomedical isn't just in the game to compete—they're setting the game rules with their mind-boggling expertise in blood management and pharmaceutical storage solutions. This October, they took center stage at the AABB and ISPE 2026 meetings, and they weren't messing around. Fresh Off the Exhibit Floor: Haier's Ambitions...
Continue Reading
Picture This: A Solo Businessman in 2026 Imagine a lone ranger running a show that used to take an entire office. That’s the magic happening with roughly 30 million solo businesses in the U.S. today, and folks, the numbers are staggering. As these one-man-bands push past clunky old systems, a big name is lighting the way: Collective. They raised a hefty $100 million to...
Continue Reading
Opening Up New Avenues for Health Care Here's a nugget from the healthcare sector that's worth chewing on. Shield HealthCare has just inked a deal with Astiva Health that opens the floodgates for eligible members in Southern California to access medical supplies through Shield's extensive network. It's a big move that aims to make health management a tad easier for folks...
Continue Reading
Luxury Trips on The Uptrend Luxury travel is surging while budget trips are taking a backseat. According to Squaremouth's latest data, high-end getaways insured for a whopping $30,000 or more shot up by 27.2% in the third quarter of 2026 compared to the same time last year. In contrast, budget-friendly jaunts under $10,000 dipped by 2.3%. Travelers seem ready to splurge...
Continue Reading
Hershey's 2026 Q3 Financial Performance: A Closer Look At the end of September, The Hershey Company (NYSE: HSY) dished out some eye-popping numbers for their third quarter. With a net sales increase of 3.0%, they clocked in at $3,275.5 million. More importantly, earnings per share-diluted shot up by a whopping 111.8%, landing at $2.88. Clearly, Hershey’s strategic moves...
Continue Reading
Breaking Barriers in Quantum Emulation If you think the quantum computing game is all about hardware, then you're missing half the picture. Enter BTQ Technologies, crash-landing into the scene by throwing open the doors of their MIMIQ emulator to a crowd of over 35,000 quantum developers through qBraid. This ain't just an upgrade—it's a seismic shift. More qubits, more...
Continue Reading
Just imagine, folks, a slice of the energy world reshaping right under our feet in good ol' Australia. That's the buzz HiTHIUM sparked at All Energy Australia as they showcased their fancy ?Power 6.9MWh, 8-hour long-duration battery storage system (BESS). It wasn’t just about the tech superiority but the strategic planting of stakes in the local energy market....
Continue Reading
Pioneering the XR Frontier Welcome to another day under the sun of cutting-edge tech, where XREAL's striking a chord with its new wired XR glasses—AURA. First off, don't let the tangled history of tech hype get to you. In the wild world of extended reality, we've seen plenty of flash, not enough substance. But XREAL's hitting the market with AURA, and I gotta say,...
Continue Reading
Folks, it’s a busy day on Wall Street, with Solink leading the charge by landing over a cool $100 million in fresh funding. Let's break this down because when startups pocket nine-digit figures, it's time to pay attention. Solink's Leap Forward Now, what’s Solink doing with all that cash? They're not scrambling for coffee money, that's for sure. Instead, this funding...
Continue Reading
Halloween at Circus Circus: A New Spin on Family Fun Ah, Circus Circus Las Vegas. It's that place that’s managed to blend screaming kids, excited parents, and a flurry of flashing lights into something resembling an amusement park—on the Strip no less. Now, they're turning up the heat for Halloween. Yup, they're rolling out half-price Midway games and Adventuredome...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Growth of the Graphene Market The Graphene market is witnessing a remarkable journey, with projections suggesting it could reach an astounding USD 4,997.1 million by 2032. This growth represents a captivating compound annual growth rate (CAGR) of 33.2% from 2024 to 2032, highlighting the material's increasing application across diverse sectors such as...
Continue Reading
Volvo Group's Third Quarter Summary Volvo Group (OTC: VLVLY, VOLV.B) has reported a challenging third quarter for 2024, characterized by normalization of demand in key segments. The company experienced a decline in net sales, recording SEK 170 billion, while adjusted operating income stood at SEK 14.1 billion with a 12% margin. These figures reflect the ongoing...
Continue Reading
Digital Security Control Market Overview The Digital Security Control Market is witnessing transformative growth, fueled by increasing cyber threats and the rising demand for sophisticated security solutions. By integrating technologies like artificial intelligence and machine learning, organizations are rethinking their approach to cybersecurity, adapting to the evolving...
Continue Reading
Carisma Therapeutics to Share Insights at Annual Conference Carisma Therapeutics Inc. (NASDAQ: CARM), known for its innovative macrophage-focused therapies, is gearing up to make waves at an upcoming virtual event. This conference will allow the company to highlight its advancements in developing therapies aimed at combating significant health issues, including cancer and...
Continue Reading
Overview of XWELL, Inc.'s Performance XWELL, Inc. (Nasdaq: XWEL), known for its innovative wellness solutions, has shown significant progress in its recent reports. The company has experienced a remarkable revenue growth of around 13% for the third quarter, compared to the same period last year. This uptick reflects a robust strategy towards sustainable profit recovery...
Continue Reading